{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:32:08Z","timestamp":1771651928329,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12887-019-1444-4","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T09:03:46Z","timestamp":1552035826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Rare cause of Hemophagocytic Lymphohistiocytosis due to mutation in PRF1 and SH2D1A genes in two children \u2013 a case report with a review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5936-5192","authenticated-orcid":false,"given":"Jayesh","family":"Sheth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riddhi","family":"Bhavsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frenny","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JBM.S46255","volume":"5","author":"MR George","year":"2014","unstructured":"George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. Journal of Blood Medicine. 2014;5:69\u201386.","journal-title":"Journal of Blood Medicine"},{"key":"1444_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/pbc.22359","volume":"54","author":"JA Niece","year":"2010","unstructured":"Niece JA, Rogers ZR, Ahmad N, Langevin AM, McClain KL. Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race. Pediatr Blood Cancer. 2010;54:424\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"1444_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12098-016-2037-y","volume":"83","author":"M Madkaikar","year":"2016","unstructured":"Madkaikar M, Shabrish S, Desai M. Current updates on classification, diagnosis and treatment of Hemophagocytic Lymphohistiocytosis (HLH). Indian J Pediatr. 2016;83:434\u201343.","journal-title":"Indian J Pediatr"},{"key":"1444_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fimmu.2014.00162","volume":"22","author":"A Waleed","year":"2014","unstructured":"Waleed A, Bousfiha A, Casonova JL, Chatila T, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency. Front Immunol. 2014;22:162. \n                    https:\/\/doi.org\/10.3389\/fimmu.2014.00162\n                    \n                  .","journal-title":"Front Immunol"},{"key":"1444_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","volume":"80","author":"JI Henter","year":"1991","unstructured":"Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand. 1991;80:428\u201335.","journal-title":"Acta Paediatr Scand"},{"key":"1444_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s12032-013-0740-3","volume":"30","author":"RS Mehta","year":"2013","unstructured":"Mehta RS, Smith ER. Hemophagocytic lymphohistiocytosis (HLH): a review of literature. Med Oncol. 2013;30:740.","journal-title":"Med Oncol"},{"key":"1444_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1086\/318796","volume":"68","author":"KG Ericson","year":"2001","unstructured":"Ericson KG, Fadeel B, Arndor SN, Soderhall C, Samualsson A, Janka G, et al. Spectrum of perforin gene mutations in familial Hemophagocytic Lymphohistiocytosis. Am J Hum Genet. 2001;68:590\u20137.","journal-title":"Am J Hum Genet"},{"key":"1444_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2006","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imasuku S, et al. HLH-2004: diagnostics and therapeutic guidelines for Hemophagocytic Lymphohistiocytosis. Pediatr Blood Cancer. 2006;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"1444_CR9","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1182\/blood-2010-03-275909","volume":"116","author":"AH Filipovich","year":"2010","unstructured":"Filipovich AH, Zhang K, Snow AL, Marsh RA. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood. 2010;116:3398\u2013408.","journal-title":"Blood."},{"key":"1444_CR10","unstructured":"HGMD Database. \n                    http:\/\/www.hgmd.cf.ac.uk\/ac\/gene.php?gene=PRF1\n                    \n                   Accessed 14 sept 2018."},{"key":"1444_CR11","unstructured":"HGMD Database. \n                    http:\/\/www.hgmd.cf.ac.uk\/ac\/gene.php?gene=SH2D1A\n                    \n                   Accessed 14 sept 2018."},{"key":"1444_CR12","first-page":"e524","volume":"36","author":"S Mhatre","year":"2014","unstructured":"Mhatre S, Madkaikar M, Jijina F, Ghosh K. Unusual clinical presentation of familial Hemophagocytic Lymphohistiocytosis Type-2. JPediatrHematol Oncol. 2014;36:e524\u20137.","journal-title":"JPediatrHematol Oncol"},{"key":"1444_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bcmd.2014.11.023","volume":"54","author":"S Mhatre","year":"2015","unstructured":"Mhatre S, Madkaikar M, Desai M, Ghosh K. Spectrum of perforin gene mutation in familial lymphohistiocytosis (FHL) patients in India. Blood cells Mol Disease. 2015;54:250\u20137.","journal-title":"Blood cells Mol Disease"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/MPH.0000000000000597","volume":"39","author":"M Madkaikar","year":"2017","unstructured":"Madkaikar M, Gupta M, Dixit A, Patil V. Predominant neurologic manifestations seen in a patient with a Biallelic Perforin1 mutation (PRF1; p.R225W). J Pediatr Hematol Oncol. 2017;39:143\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1444_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.","journal-title":"Nucleic Acids Res"},{"key":"1444_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/humu.20274","volume":"27","author":"BK Zur Stadt","year":"2006","unstructured":"Zur Stadt BK, Kolberg K, Schneppenheim R, Kabisch H, Janka G, et al. Mutation Spectrum in children with primary Hemophagocytic Lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D,STX11, and RAB27A. Hum Mutat. 2006;27:62\u20138.","journal-title":"Hum Mutat"},{"key":"1444_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/pro.2265","volume":"22","author":"AN Omar","year":"2013","unstructured":"Omar AN, Gursoy A, Gurgey A, Keskin O. Structural and functional analysis of perforin mutations in association with clinical data of familial hemophagocytic lymphohistiocytosis type 2 (FHL2) patients. Protein Sci. 2013;22:823\u201339.","journal-title":"Protein Sci"},{"key":"1444_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1046\/j.1365-2141.2003.04298.x","volume":"121","author":"I Ueda","year":"2003","unstructured":"Ueda I, Morimoto A, Inaba T, Yagi T, Hibi S, Sugimoto T, et al. Characteristic perforin gene mutations of hemophagocytic lymphohistiocytosis patients in Japan. Br J Haematol. 2003;121:503\u201310.","journal-title":"Br J Haematol"},{"key":"1444_CR19","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1182\/blood-2002-04-1030","volume":"100","author":"R Clementi","year":"2002","unstructured":"Clementi R, Emmi L, Maccario R, Liotta F, Moretta L, Danesino C, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in sibling carrying PRF1mutation. Blood. 2002;100:2266\u20137.","journal-title":"Blood."},{"key":"1444_CR20","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2011-08-374355","volume":"119","author":"J Chia","year":"2012","unstructured":"Chia J, Thia K, Brennan AJ, Little M, Williams B, Lopez JA, et al. Fatal immune dysregulation due to gain of glycosylation mutation in lymphocyte perforin. Blood. 2012;119:1713\u20136.","journal-title":"Blood."},{"key":"1444_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood.V99.1.61","volume":"99","author":"K Kogawa","year":"2002","unstructured":"Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002;99:61\u201366.","journal-title":"Blood."},{"key":"1444_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1046\/j.1365-2141.2002.03534.x","volume":"117","author":"J Feldmann","year":"2002","unstructured":"Feldmann J, Deist F, Ouache\u00b4e-Chardin M, Certain S, Sarah A, Quartier P, et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2002;117:965\u201372.","journal-title":"Br J Haematol"},{"key":"1444_CR23","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1182\/blood-2001-12-0260","volume":"100","author":"EM Schneider","year":"2002","unstructured":"Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE. Hemophagocytic lymphohistiocytosis (HLH) is associated with deficiencies of cellular cytolysis but normal expression of apoptosis related transcripts. Blood. 2002;100:2891\u20138.","journal-title":"Blood."},{"key":"1444_CR24","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1182\/blood-2004-08-3296","volume":"105","author":"E Ishii","year":"2005","unstructured":"Ishii E, Ueda I, Shirakawa R, Yamamoto K, Horiuchi H, Ohga S, et al. Genetic subtype of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocytes\/natural killer cell function. Blood. 2005;105:3442\u20138.","journal-title":"Blood."},{"key":"1444_CR25","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1182\/blood-2003-06-2171","volume":"103","author":"H Katano","year":"2003","unstructured":"Katano H, Ali MA, Patera AC, Catalafamo M, Jaffe ES, Kimura H, et al. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood. 2003;103:1244\u201352.","journal-title":"Blood."},{"key":"1444_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/26683","volume":"395","author":"J Sayos","year":"1998","unstructured":"Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, et al. The X-linked lymphoprolifertaive-disease gene product SAP regulates signal induced through the co-receptor SLAM. Nature. 1998;395:462\u20139.","journal-title":"Nature."},{"key":"1444_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.0105-2896.2005.00230.x","volume":"203","author":"KE Nichols","year":"2005","unstructured":"Nichols KE, Ma CS, Cannons JL, Schwartzberg PL, Tangye SG. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev. 2005;203:180\u201399.","journal-title":"Immunol Rev"},{"key":"1444_CR28","doi-asserted-by":"crossref","unstructured":"Sumegi J, Seemayer TA, Huang D, Davis JR, Morra M, Gross TG, et al. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses. Leuk Lymphoma. 2002;43:1189-01.","DOI":"10.1080\/10428190290026240"},{"key":"1444_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.192.3.337","volume":"192","author":"S Parolini","year":"2000","unstructured":"Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, et al. X-linked lymphoprolifertaive disease: 2B4 molecules displaying inhibitory rather than activating function are reponsible for the inability of natural killer cells to kill Epstein-Barr virus infected cells. J Exp Med. 2000;192:337\u201346.","journal-title":"J Exp Med"},{"key":"1444_CR30","doi-asserted-by":"crossref","unstructured":"Benoit L., Wang X., Pabst H.F., Dutz, J, Tan R. Defective NK cell activation in X-linked lymphoproliferative disease. J Immunol. 2000;165:3549\u201353.","DOI":"10.4049\/jimmunol.165.7.3549"},{"key":"1444_CR31","unstructured":"Sumegi J, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, et al. Correlation of mutation of SH2D1A gene and Epstein-Barr virus infection with clinical phenotypes and outcome in X-linked lymphoproliferative disease. Blood. 2000;96:3118-25."},{"key":"1444_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00443367","volume":"140","author":"GE Janka","year":"1983","unstructured":"Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983;140:221\u201330.","journal-title":"Eur J Pediatr"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1444-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1444-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1444-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:11:38Z","timestamp":1583539898000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1444-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1444-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"assertion":[{"value":"9 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present case report has been approved by the institutional ethics committee [FRIGE\u2019s Institute of Human Genetics] with approval number FRIGE\/IEC\/14\/2016 dated 19th November 2016. This process is in accordance with Helsinki declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent was obtained from all study participants [parents (adults), legal guardians (parents) consented on behalf of their minor children], for genetic testing, inclusion in the study as well as publication of their clinical details and\/or clinical images. A copy of the written consent is available for review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest (financial or non-financial) in the present study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"73"}}